Navigation Links
Volcano Corporation Announces Litigation Status
Date:2/5/2010

SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) today announced that the jury in the litigation filed by Lightlab Imaging, Inc. on January 7, 2009 in the Superior Court of Massachusetts, Suffolk County reached a verdict against Volcano and its wholly owned subsidiary, Axsun Technologies.  In December 2008, Volcano acquired Axsun, which had an agreement to supply tunable lasers to Lightlab for use in Lightlab's OCT (Optical Coherence Technology) imaging products until April 2016, with exclusivity in the field of coronary artery imaging expiring in April 2014.  Since the acquisition, Axsun has continued to supply lasers to Lightlab.  The jury findings included that the contract specification for the laser Axsun supplies to Lightlab is a trade secret of Lightlab, that Axsun agreed not to sell any tunable lasers for use in cardiology imaging to any third party during the exclusivity period in the contract, and that Axsun breached its contract with Lightlab.  The jury further found that Volcano intentionally interfered with Lightlab's advantageous business relationship with Axsun. The jury was not charged with determining damages, which, if any, would be established in a second jury trial.

Volcano intends to appeal the jury verdict and is not in the position to estimate the possible loss attributable to this verdict. Volcano does not believe that this development will have a material impact on Volcano's OCT program or Axsun's business.

Volcano Corporation offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use digital and rotational IVUS imaging catheters, and advanced functionality options, such as VH® IVUS tissue characterization and ChromaFlo®. Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters. Currently, more than 4,700 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. Volcano's wholly-owned subsidiary, Axsun Technologies, develops and manufactures optical monitors, lasers and optical engines used in telecommunications, spectroscopy and other industrial applications. For more information, visit the company's website at www.volcanocorp.com.

This news release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this news release regarding the LightLab litigation that are not historical facts may be considered "forward-looking statements," including statements relating to the impact of the LightLab litigation.  Forward-looking statements are subject to risks and uncertainties, which may cause Volcano's results to differ materially and adversely from the statements contained herein.  Some of the potential risks and uncertainties that could cause actual results to differ from the results predicted are detailed in the company's annual report on Form 10-K, quarterly reports on Form 10-Q and other filings made with the Securities and Exchange Commission.  Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

SOURCE Volcano Corporation

RELATED LINKS
http://www.volcanocorp.com

'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Announces Preliminary Record Revenues for Fourth Quarter 2009; Total Year Revenues are Expected to Exceed Prior Guidance
2. Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
3. Volcano Announces Installed Base Growth Milestone
4. Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging
5. Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
6. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
7. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
8. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
9. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
10. Oxford Finance Corporation Closes $25 Million Credit Facility with EUSA Pharma
11. Vystar Corporation Engages The Investor Relations Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com ... and dermatology biopharmaceutical company, today disclosed terms of ... (the "Definitive Financing") it entered into on March ... who are referred to in the Definitive Financing ... with the Securities and Exchange Commission.   ...
(Date:3/23/2017)... , March 23, 2017 The key ... population, increasing diabetic population, accelerating economic growth and increasing healthcare ... industry are higher life expectancy of ESRD patients, rising demand ... markets. However, the expansion of the market is hindered by ... ...
(Date:3/23/2017)... As a result of diagnostic technology ... of allergic diseases, cutting edge developments in targeted ... ways in which pharmaceutical and biotech companies are ... be both a high quality meeting and a ... immunologists, research scholars and doctors. The event will ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... 24, 2017 , ... According to a new study by NCPA Senior Fellow ... obey the rules Congress has directed the CBO to follow. The CBO itself previously ... restore. Yet, it estimates a reduction in employer-based coverage due to the GOP reform, ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mlynarek Insurance Agencies, ... families and business owners across eastern Michigan, is connecting with the Oxford/Orion FISH ... financial difficulties. , The Oxford/Orion FISH Food Pantry works to ensure homeless, hungry, ...
(Date:3/24/2017)... PA (PRWEB) , ... March 24, 2017 , ... ... Oncology Nursing Society (ONS) wanted to create a communications platform that positions them ... this goal, Elliance and ONS reinvented their online publication as an always-on, always-fresh ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of Enea, ... pleased to announce Westchester resident Lauren C. Enea has joined the firm as an ... will concentrate her practice in elder law, Medicaid planning and applications, and Wills, Trusts ...
(Date:3/24/2017)... Southlake, Texas (PRWEB) , ... March 24, 2017 ... ... make 2017 the year of enhancements, upgrading their training and leads programs. , ... Empower University. Reserved for elite sales agents, Performance Partners is designed to teach ...
Breaking Medicine News(10 mins):